2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Arterial Embolization: new trials by email Literature Review of Arterial Embolization trials Research Report on Arterial Embolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases Arterial Embolization, Pembrolizumab, Peptide Receptor Radionuclide Therapy (PRRT) using 177Lu-DOTA0-Tyr3-Octreotate - Metastatic Malignant Neoplasm in the Liver, Neuroendocrine Neoplasm | Phase 2 | Completed | Nicholas Fidelman, MD | 32 | 2018-08-27 | 2026-08-28 |
| [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer 18F-Fluoromisonidazole, Arterial Embolization, Computed Tomography - Adult Liver Carcinoma, Liver Cirrhosis | Phase 2 | Completed | Stanford University | 5 | 2016-09-13 | 2024-01-31 |
Carcinoma, Hepatocellular (1) · Liver Cirrhosis (1) · Neuroendocrine Tumors (1)
Nicholas Fidelman, MD (1) · Stanford University (1)
United States (2)
Nicholas Fidelman, MD (1) · Rajesh Shah (1)
P30CA124435 (1)